<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Jing, Zhi-Cheng</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Beraprost Plus Sildenafil Effective in Pulmonary Arterial Hypertension</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-18</style></pages><abstract><style  face="normal" font="default" size="100%">Combination treatment of beraprost and sildenafil results in improved 6-minute walk test distance and decreases N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and time to worsening in patients with pulmonary arterial hypertension. This article presents data from the Beraprost Combined Therapy With Sildenafil for Pulmonary Arterial Hypertension study [BEST; ChiCTR-TCC-12002776].</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>